for Oncological Screening
mint Lesion™ supports radiologists in performing the radiological read for oncological screening. Starting with a reading profile developed for prostate screening, the application includes new dedicated reading procedures for the assessment of images obtained using multi-parametric MRI, including T2 weighted images, DCE, and DWI (ADC, b-value).
By means of standardized graphical prostata schemes and integrated help with representative images for different scorings, you can easily document and communicate lesion location, as well as the generated lesion scoring according to PI-RADS classification.
for Oncological Staging
mint Lesion™ supports radiologists in performing the radiological read for oncological staging. The TNM classification for malignancies is the most common approach to document the stage of a cancer disease. The staging heavily relies upon significant key observations in medical image data – therefore, radiological reports are crucial for the assessment of potential therapy opportunities.
mint Lesion™ knows about the intricacies of particular criteria and guidelines and automatically determines the stage of disease based on radiological image annotations, classifications, and further clinical parameters. The profiles include a variety of TNM tumor entities, staging and transplant scoring of liver disease.
for Therapy Response Evaluation
mint Lesion™ supports radiologists in performing the follow-up assessment. Therapy monitoring based on standardized criteria are increasingly applied in clinical routine. Meanwhile, more and more oncologists demand results, which were evaluated and assessed in compliance with predefined criteria – e. g. RECIST.
With mint Lesion™, you can conduct such sophisticated evaluations easily and within a short time. Assessments conform with international established standards or follow your adapted guidelines. Furthermore, you do not need to master any statistical analysis, mint Lesion™ performs the interpretation for you automatically.
in line with…
- Prostate | PI-RADS v2
- Mamma | BI-RADS
- Lung | Lung-RADS
- Liver | LI-RADS
- RECIST 1.1
- RECIST 1.0
- irRECIST 1.1
- mRECIST HCC
- mRECIST Mesoth.
- Customizable Profiles
In most cases, very individual
unstructured reports in prose.
mint Lesion™ generates holistic and comprehensive reports
with automated determination of clinical results.
Modern targeted therapies play an increasingly important role in the treatment of cancer patients in the era of personalized medicine. Clinical studies already demonstrated considerable tumor response under treatment with new agents such as Sorafenib in HCC and RCC, or Imatinib in GIST. In the face of these modern targeted therapies and increasingly multi-modal therapy approaches, new challenges and opportunities arise for oncological procedures and radiological image-based diagnoses.
A major pitfall in tumor response monitoring is the increasing incidence of mixed response in targeted therapies. A typical example is the treatment with Vemurafenib in metastatic melanoma with specific B-RAF mutation. Response to Vemurafenib is typically not durable because of suddenly developing resistances. An early detection of disease progression provides improved outcome of subsequent therapies, e.g. with the monoclonal antibody Ipilimumab.
A 44-year-old patient with metastatic melanoma treated with Vemurafenib was radiologically assessed according to the RECIST 1.1 guidelines. A first follow-up CT scan eight weeks after treatment start (Baseline) showed mixed response… Read more
mint Lesion™ offers an integrated solution that combines documented findings from the radiologist with structured reporting for other clinicians in a very intuitive way – this interplay is crucial to an efficient application in clinical routine.- Prof. Dr. Werner Jaschke \\ University Hospital Innsbruck
Mint Medical has designed an incredibly robust, comprehensive and easy to use software package that has revolutionized structured reporting in the assessment of treatment response in cancer patients. mint Lesion™ really is the best.- Prof. Dr. Marilyn Siegel \\ Washington University St. Louis
Using mint Lesion™, I have observed a paradigm shift that is revolutionizing my approach to oncologic patients.- Dr. Daniele Regge \\ Candiolo Cancer Institute Turin
We professionalized our oncological assessment workflows by application of mint Lesion™.- Prof. Dr. Georg Bongartz \\ University Hospital Basel
Good integration in the existing IT was important to us – appropriate interfaces to RIS and PACS were implemented quickly and professionally.- Prof. Dr. Elmar Kotter \\ University Hospital Freiburg
mint Lesion™ knows about the partially complex subtleties of assessment criteria, which makes the assessment of lesions a lot easier compared to conventional workstations.- Prof. Dr. Philippe Pereira \\ SLK Clinics Heilbronn
mint Lesion™ 3.0 allows for fast and adequate TNM staging and provides an excellent schematic overview of an individual patient’s disease for oncologists, surgeons, and the patients.- PD Dr. Thorsten Persigehl \\ University Hospital Cologne
The intuitive workflow is perfectly suited for the normal workflow of oncological radiological diagnosis. Even a relatively inexperienced user can get the hang of it quite quickly.- Prof. Dr. Marika Ganten \\ German Cancer Research Center
Start mint Lesion™ directly from your RIS / PACS while preserving the working context. Relevant image data is automatically synchronized with your PACS and results can be integrated into your RIS report.